Cancer Research The Future of Cancer Research: Science and Patient Impact Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 53, 3860-3864, September 1, 1993]
© 1993 American Association for Cancer Research
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vile, R. G.
Right arrow Articles by Hart, I. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vile, R. G.
Right arrow Articles by Hart, I. R.

Use of Tissue-specific Expression of the Herpes Simplex Virus Thymidine Kinase Gene to Inhibit Growth of Established Murine Melanomas following Direct Intratumoral Injection of DNA

Richard G. Vile and Ian R. Hart

Biology of Metastasis Laboratory, Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London, WC2A 3PX, United Kingdom

We report here the use of the 5' flanking region of the murine tyrosinase gene to direct expression of the herpes simplex virus thymidine kinase (tk) gene specifically to murine melanoma cells, whilst not permitting expression in a range of other cell types. Expression of the herpes simplex virus tk gene from the tyrosinase promoter in melanoma cells rendered them sensitive to killing by ganciclovir (100% cell death of a tk-expressing B16 clone after 12 days in culture at 1 µg/ml ganciclovir). We also observed a substantial bystander killing effect when expressing cells were mixed with nontransfected parental B16 cells. When transfected murine melanoma cells expressing tk were injected into syngeneic mice both their tumorigenicity and experimental metastatic potential were abrogated completely when the mice were treated with ganciclovir (27 of 28 mice treated with water developed progressively growing tumors versus 1 of 30 in the ganciclovir-treated group). Direct injection of the tk gene under control of the tyrosinase promoter into established tumors in mice, followed by treatment with ganciclovir, led to significant reductions in resultant tumor size relative to the size of tumor developing in mice treated with water (median tumor weight, 1.65 g versus 2.75 g). Therefore, direct transfer of recombinant genes by injection of DNA can significantly reduce established tumor burden in vivo.

Received 6/14/93. Accepted 7/19/93.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
L. Sanchez-Perez, T. Kottke, G. A. Daniels, R. M. Diaz, J. Thompson, J. Pulido, A. Melcher, and R. G. Vile
Killing of Normal Melanocytes, Combined with Heat Shock Protein 70 and CD40L Expression, Cures Large Established Melanomas
J. Immunol., September 15, 2006; 177(6): 4168 - 4177.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. D. Boucher, M. M. Im, S. O. Freytag, and D. S. Shewach
A novel mechanism of synergistic cytotoxicity with 5-fluorocytosine and ganciclovir in double suicide gene therapy.
Cancer Res., March 15, 2006; 66(6): 3230 - 3237.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Sanchez-Perez, T. Kottke, R. M. Diaz, A. Ahmed, J. Thompson, H. Chong, A. Melcher, S. Holmen, G. Daniels, and R. G. Vile
Potent Selection of Antigen Loss Variants of B16 Melanoma following Inflammatory Killing of Melanocytes In vivo
Cancer Res., March 1, 2005; 65(5): 2009 - 2017.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. Ren, R. Strube, X. Zhang, S.-Y. Chen, and X. F. Huang
Potent Tumor-Specific Immunity Induced by an In vivo Heat Shock Protein-Suicide Gene-Based Tumor Vaccine
Cancer Res., September 15, 2004; 64(18): 6645 - 6651.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
K. Cusato, A. Bosco, R. Rozental, C. A. Guimaraes, B. E. Reese, R. Linden, and D. C. Spray
Gap Junctions Mediate Bystander Cell Death in Developing Retina
J. Neurosci., July 23, 2003; 23(16): 6413 - 6422.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. M. Nettelbeck, A. A. Rivera, C. Balague, R. Alemany, and D. T. Curiel
Novel Oncolytic Adenoviruses Targeted to Melanoma: Specific Viral Replication and Cytolysis by Expression of E1A Mutants from the Tyrosinase Enhancer/Promoter
Cancer Res., August 15, 2002; 62(16): 4663 - 4670.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
M. M. Alauddin, A. Shahinian, E. M. Gordon, J. R. Bading, and P. S. Conti
Preclinical Evaluation of the Penciclovir Analog 9-(4-[18F]Fluoro-3-Hydroxymethylbutyl)Guanine for In Vivo Measurement of Suicide Gene Expression with PET
J. Nucl. Med., November 1, 2001; 42(11): 1682 - 1690.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. Yaghoubi, J. R. Barrio, M. Dahlbom, M. Iyer, M. Namavari, N. Satyamurthy, R. Goldman, H. R. Herschman, M. E. Phelps, and S. S. Gambhir
Human Pharmacokinetic and Dosimetry Studies of [18F]FHBG: A Reporter Probe for Imaging Herpes Simplex Virus Type-1 Thymidine Kinase Reporter Gene Expression
J. Nucl. Med., August 1, 2001; 42(8): 1225 - 1234.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. Casado, J. Gomez-Navarro, M. Yamamoto, Y. Adachi, C. J. Coolidge, W. O. Arafat, S. D. Barker, M. H. Wang, P. J. Mahasreshti, A. Hemminki, et al.
Strategies to Accomplish Targeted Expression of Transgenes in Ovarian Cancer for Molecular Therapeutic Applications
Clin. Cancer Res., August 1, 2001; 7(8): 2496 - 2504.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. V. Iyengar, C. A. Pawlik, E. J. Krull, D. A. Phelps, R. A. Burger, L. C. Harris, P. M. Potter, and M. K. Danks
Use of a Modified Ornithine Decarboxylase Promoter to Achieve Efficient c-MYC- or N-MYC-regulated Protein Expression
Cancer Res., April 1, 2001; 61(7): 3045 - 3052.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
F. Bazzoni and E. Regalia
Triggering of Antitumor Activity Through Melanoma-specific Transduction of a Constitutively Active Tumor Necrosis Factor (TNF) R1 Chimeric Receptor in the Absence of TNF-{{alpha}}
Cancer Res., February 1, 2001; 61(3): 1050 - 1057.
[Abstract] [Full Text]

Home page
 IOVSHome page
S. Shiose, T. Sakamoto, H. Yoshikawa, Y. Hata, Y. Kawano, T. Ishibashi, H. Inomata, K. Takayama, and H. Ueno
Gene Transfer of a Soluble Receptor of VEGF Inhibits the Growth of Experimental Eyelid Malignant Melanoma
Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2395 - 2403.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
M. Mesnil and H. Yamasaki
Bystander Effect in Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Cancer Gene Therapy: Role of Gap-junctional Intercellular Communication1
Cancer Res., August 1, 2000; 60(15): 3989 - 3999.
[Abstract] [Full Text]

Home page
 JNCI J Natl Cancer InstHome page
D. Vandier, V. Calvez, L. Massade, A. Gouyette, L. Mickley, T. Fojo, and O. Rixe
Transactivation of the Metallothionein Promoter in Cisplatin-Resistant Cancer Cells: a Specific Gene Therapy Strategy
J Natl Cancer Inst, April 19, 2000; 92(8): 642 - 647.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Bateman, F. Bullough, S. Murphy, L. Emiliusen, D. Lavillette, F.-L. Cosset, R. Cattaneo, S. J. Russell, and R. G. Vile
Fusogenic Membrane Glycoproteins As a Novel Class of Genes for the Local and Immune-mediated Control of Tumor Growth
Cancer Res., March 1, 2000; 60(6): 1492 - 1497.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
P. D. Boucher, L. J. Ostruszka, and D. S. Shewach
Synergistic Enhancement of Herpes Simplex Virus Thymidine Kinase/Ganciclovir-mediated Cytotoxicity by Hydroxyurea
Cancer Res., March 1, 2000; 60(6): 1631 - 1636.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
M. Korbelik and G. J. Dougherty
Photodynamic Therapy-mediated Immune Response against Subcutaneous Mouse Tumors
Cancer Res., April 1, 1999; 59(8): 1941 - 1946.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Z. Rubsam, P. D. Boucher, P. J. Murphy, M. KuKuruga, and D. S. Shewach
Cytotoxicity and Accumulation of Ganciclovir Triphosphate in Bystander Cells Cocultured with Herpes Simplex Virus Type 1 Thymidine Kinase-expressing Human Glioblastoma Cells
Cancer Res., February 1, 1999; 59(3): 669 - 675.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. M. Diaz, T. Eisen, I. R. Hart, and R. G. Vile
Exchange of Viral Promoter/Enhancer Elements with Heterologous Regulatory Sequences Generates Targeted Hybrid Long Terminal Repeat Vectors for Gene Therapy of Melanoma
J. Virol., January 1, 1998; 72(1): 789 - 795.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Su, R. Lu, J. C. Chang, and Y. W. Kan
Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic mice
PNAS, December 9, 1997; 94(25): 13891 - 13896.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
C. S. Crumpacker
Ganciclovir
N. Engl. J. Med., September 5, 1996; 335(10): 721 - 729.
[Full Text] [PDF]

Home page
 BMJHome page
K Sikora
Current Issues in Cancer: Genes dreams and cancer
BMJ, May 7, 1994; 308(6938): 1217 - 1221.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.